Medications

Reevaluating pneumococcal vaccine guidance: An analysis

If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal vaccine at age 50 would ...

Diseases, Conditions, Syndromes

UMSOM and GRAS begin second typhoid conjugate vaccine study in Africa

A new study has been launched in Burkina Faso for Bharat Biotech's typhoid conjugate vaccine (TCV). It is the second clinical study underway in Africa for the vaccine and the first in West Africa. The vaccine study is a joint ...

Diseases, Conditions, Syndromes

Pneumococcal vaccine recs cause confusion among docs

(HealthDay)—While primary care physicians overwhelmingly recommend pneumococcal vaccines, there is a gap in their knowledge of how to implement related vaccine recommendations, according to a study published in the Journal ...

Diseases, Conditions, Syndromes

CDC: HPV vaccination rates increasing among adolescents

(HealthDay)—Human papillomavirus (HPV) vaccination coverage increased 5.1 percentage points from 2016 to 2017, and there was also an increase in the number of adolescents up to date with HPV vaccinations, according to research ...

Diseases, Conditions, Syndromes

Drop in childhood pneumococcal, Hib deaths from 2000 to 2015

(HealthDay)—Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) deaths in children decreased between 2000 and 2015, following introduction of the pneumococcal conjugate vaccine (PCV) and Hib vaccine, according ...

Diseases, Conditions, Syndromes

Vaccination coverage high for children aged 19 to 35 months

(HealthDay)—Vaccination coverage has remained above 90 percent for many vaccinations among young children, and progress is being made toward immunization information systems (IISs) program goals, according to two studies ...

Diseases, Conditions, Syndromes

Which vaccinations should I get as an adult?

Before vaccines were developed, infectious diseases such as diphtheria, tetanus and meningitis were the leading cause of death and illness in the world. Vaccines are one of the greatest public health achievements in history, ...

Oncology & Cancer

Single-dose PCV13 immunogenic, safe in pediatric oncology

(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.

Pediatrics

Post-PCV13 drop in Streptococcus pneumoniae bacteremia

(HealthDay)—Introduction of seven-valent and 13-valent pneumococcal conjugate vaccine (PCV13) correlated with a reduction in Streptococcus pneumoniae bacteremia, according to a review published online March 10 in Pediatrics.

Diseases, Conditions, Syndromes

Bell's palsy tied to quadrivalent meningococcal vaccine

(HealthDay)—Bell's palsy is the only prespecified adverse event associated with the MenACWY-CRM quadrivalent meningococcal conjugate vaccine, according to a study published online Dec. 26 in Pediatrics.

page 2 from 6